305 related articles for article (PubMed ID: 28186971)
1. Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.
Jiang B; Zhang Y; Liu J; Tsigkou A; Rapti M; Lee MH
Oncotarget; 2017 Apr; 8(14):22685-22699. PubMed ID: 28186971
[TBL] [Abstract][Full Text] [Related]
2. Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy.
Jiang B; Liu J; Lee MH
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641935
[TBL] [Abstract][Full Text] [Related]
3. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
4. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
5. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
[TBL] [Abstract][Full Text] [Related]
7. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
Morrison CJ; Overall CM
J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
[TBL] [Abstract][Full Text] [Related]
8. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Park JM; Kim A; Oh JH; Chung AS
Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
[TBL] [Abstract][Full Text] [Related]
9. Translocating a High-Affinity Designer TIMP-1 to the Cell Membrane for Total Renal Carcinoma Inhibition: Putting the Prion Protein to Good Use.
Jiang B; Xu Y; Zhang Y; Lee MH
Mol Cell Biol; 2019 Sep; 39(18):. PubMed ID: 31208977
[No Abstract] [Full Text] [Related]
10. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
12. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
Kajita M; Itoh Y; Chiba T; Mori H; Okada A; Kinoh H; Seiki M
J Cell Biol; 2001 May; 153(5):893-904. PubMed ID: 11381077
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
[TBL] [Abstract][Full Text] [Related]
15. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
Chernov AV; Sounni NE; Remacle AG; Strongin AY
J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
[TBL] [Abstract][Full Text] [Related]
17. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
Miller MC; Manning HB; Jain A; Troeberg L; Dudhia J; Essex D; Sandison A; Seiki M; Nanchahal J; Nagase H; Itoh Y
Arthritis Rheum; 2009 Mar; 60(3):686-97. PubMed ID: 19248098
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
19. Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
Remacle AG; Shiryaev SA; Golubkov VS; Freskos JN; Brown MA; Karwa AS; Naik AD; Howard CP; Sympson CJ; Strongin AY
J Biol Chem; 2013 Jul; 288(28):20568-80. PubMed ID: 23733191
[TBL] [Abstract][Full Text] [Related]
20. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
